% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Vogel:285634,
author = {Vogel, Adam P and Graf, Lisa and Weiß, Merit and Chan,
Cheuk S J and Hepworth, Graham and Synofzik, Matthis},
title = {{D}evelopment and validation of the dysarthria impact
scale: a patient-reported outcome for motor speech
disorders.},
journal = {Journal of neurology},
volume = {273},
number = {3},
issn = {0367-004X},
address = {[Darmstadt]},
publisher = {Steinkopff},
reportid = {DZNE-2026-00273},
pages = {195},
year = {2026},
abstract = {Impaired speech due to dysarthria significantly impacts
quality of life. Patient-reported outcomes (PROs) offer
critical insight into the lived experience of communication
disability and are central to regulatory frameworks for
patient-focused drug development.To develop and validate the
Dysarthria Impact Scale (DIS), a brief PRO designed to
assess the impact of motor speech disorders on quality of
life across neurological conditions.A multi-site,
cross-sectional study was conducted with 244 participants,
including individuals with Huntington's disease, Parkinson's
disease, hereditary ataxias, and head and neck cancer, and
healthy controls. The 22-item DIS was developed using expert
input and patient feedback and evaluated alongside reference
tools (Voice Handicap Index and SF-36). Item reduction
procedures yielded two shorter versions (DIS-17 and DIS-6).
Validity, reliability, and sensitivity/specificity analyses
were performed, and minimal clinically important differences
(MCIDs) were estimated using distribution-based methods.All
DIS versions showed strong convergent validity with the VHI
(r = -0.85) and SF-36 (r = 0.72) and were correlated with
blinded perceptual speech ratings. DIS-17 and DIS-6 achieved
comparable sensitivity (0.93 and 0.88) and specificity (0.84
and 0.86, respectively). Test-retest reliability was high (r
= 0.98), with estimated MCIDs and within-subject variability
provided. Group differences were observed, with lower DIS
scores in ataxia and Parkinson's disease compared to
Huntington's disease.The DIS is a valid, reliable, and
practical PRO for quantifying the impact of dysarthria on
quality of life. Longitudinal responsiveness remains to be
established.},
keywords = {Humans / Dysarthria: diagnosis / Dysarthria: etiology /
Dysarthria: psychology / Male / Female / Middle Aged /
Patient Reported Outcome Measures / Aged / Cross-Sectional
Studies / Adult / Reproducibility of Results / Quality of
Life / Severity of Illness Index / Clinical trials (Other) /
Dysarthria (Other) / Patient-reported outcome (Other) /
Questionnaire (Other) / Speech (Other) / Survey (Other)},
cin = {AG Gasser},
ddc = {610},
cid = {I:(DE-2719)1210000},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41805906},
pmc = {pmc:PMC12975812},
doi = {10.1007/s00415-026-13740-1},
url = {https://pub.dzne.de/record/285634},
}